Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 3
2007 3
2008 5
2009 3
2010 5
2011 10
2012 5
2013 7
2014 2
2015 4
2016 3
2017 3
2018 2
2019 3
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22448595

63 results
Results by year
Filters applied: . Clear all
Page 1
The therapeutic potential of the endocannabinoid system for Alzheimer's disease.
Karl T, Cheng D, Garner B, Arnold JC. Karl T, et al. Expert Opin Ther Targets. 2012 Apr;16(4):407-20. doi: 10.1517/14728222.2012.671812. Epub 2012 Mar 27. Expert Opin Ther Targets. 2012. PMID: 22448595 Review.
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.
Karl T, Garner B, Cheng D. Karl T, et al. Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):142-160. doi: 10.1097/FBP.0000000000000247. Behav Pharmacol. 2017. PMID: 27471947 Review.
The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses.
Bisogno T, Di Marzo V. Bisogno T, et al. Curr Pharm Des. 2008;14(23):2299-3305. doi: 10.2174/138161208785740027. Curr Pharm Des. 2008. PMID: 18781980 Review.
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease.
Bedse G, Romano A, Lavecchia AM, Cassano T, Gaetani S. Bedse G, et al. J Alzheimers Dis. 2015;43(4):1115-36. doi: 10.3233/JAD-141635. J Alzheimers Dis. 2015. PMID: 25147120 Review.
Targeting the endocannabinoid system in Alzheimer's disease.
Koppel J, Davies P. Koppel J, et al. J Alzheimers Dis. 2008 Nov;15(3):495-504. doi: 10.3233/jad-2008-15315. J Alzheimers Dis. 2008. PMID: 18997302 Free PMC article. Review.
The endocannabinoid system and Alzheimer's disease.
Benito C, Núñez E, Pazos MR, Tolón RM, Romero J. Benito C, et al. Mol Neurobiol. 2007 Aug;36(1):75-81. doi: 10.1007/s12035-007-8006-8. Epub 2007 Sep 5. Mol Neurobiol. 2007. PMID: 17952652
Role of the endocannabinoid system in Alzheimer's disease: new perspectives.
Pazos MR, Núñez E, Benito C, Tolón RM, Romero J. Pazos MR, et al. Life Sci. 2004 Sep 3;75(16):1907-15. doi: 10.1016/j.lfs.2004.03.026. Life Sci. 2004. PMID: 15306158 Review.
Cannabidiol as potential anticancer drug.
Massi P, Solinas M, Cinquina V, Parolaro D. Massi P, et al. Br J Clin Pharmacol. 2013 Feb;75(2):303-12. doi: 10.1111/j.1365-2125.2012.04298.x. Br J Clin Pharmacol. 2013. PMID: 22506672 Free PMC article. Review.
New and emerging treatments for Alzheimer's disease.
Corbett A, Ballard C. Corbett A, et al. Expert Opin Emerg Drugs. 2012 Jun;17(2):147-56. doi: 10.1517/14728214.2012.675327. Epub 2012 Mar 23. Expert Opin Emerg Drugs. 2012. PMID: 22439621 Review.
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes.
Bak AM, Egefjord L, Gejl M, Steffensen C, Stecher CW, Smidt K, Brock B, Rungby J. Bak AM, et al. Expert Opin Ther Targets. 2011 Oct;15(10):1153-62. doi: 10.1517/14728222.2011.600691. Epub 2011 Jul 12. Expert Opin Ther Targets. 2011. PMID: 21749267 Review.
63 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback